BPG is committed to discovery and dissemination of knowledge
Citation
Berkowitz JC, Stein-Fishbein J, Khan S, Furie R, Sultan KS. Declining use of combination infliximab and immunomodulator for inflammatory bowel disease in the community setting. World J Gastrointest Pharmacol Ther 2018; 9(1): 8-13 [PMID: 29430323 DOI: 10.4292/wjgpt.v9.i1.8]
Please LOGIN to submit a new comment.